ObsEva SA. EBIT

ObsEva SA. (OBSV) currently reports a EBIT of $-35M as of December 2022. That compares with $-55M in the prior-year period — up 37.1% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore ObsEva SA.'s EBIT history and peer comparisons.

ObsEva SA.'s EBIT increased from $-55M to $-35M — a 37.1% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ObsEva SA.'s EBIT of $-35M is lower than the Healthcare sector average of $23B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

ObsEva SA. reported $-35M in EBIT as of December 2022. That compares with $-55M in the prior-year period — up 37.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-35M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for ObsEva SA., and consider following OBSV for alerts when major investors trade the stock.